Loading...
Please wait, while we are loading the content...
Phagocytic cells synthesize 19-nor-10-keto-25-hydroxyvitamin D3, a metabolite that may induce differentiation of the human monoblastic cell line U937.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Gray, T. Kenney Millington, David S. Maltby, David A. Williams, Mark E. Cohen, Michael S. Dodd, Richard C. |
| Copyright Year | 1985 |
| Abstract | Phagocytic cells, including normal human blood neutrophils and monocytes, metabolize 25-hydroxyvitamin D3 in vitro to more polar metabolites. Cells of the human monoblastic cell line U937 produced three metabolites when incubated with 25-hydroxyvitamin D3. One of these metabolites, previously designated peak III, has its maximal absorbance at 310 nm. Mass spectral analysis of the trimethylsilylated derivatives of peak III revealed a spectral pattern very similar to that published for the trimethylsilylated derivatives of 19-nor-10-keto-25-hydroxyvitamin D3. The biosynthetic 19-nor-10-keto-25-hydroxyvitamin D3 was active in the induction of differentiation of U937 cells. |
| File Format | PDF HTM / HTML |
| DOI | 10.1073/pnas.82.23.8218 |
| PubMed reference number | 3865223 |
| Journal | Medline |
| Volume Number | 82 |
| Issue Number | 23 |
| Alternate Webpage(s) | http://www.pnas.org/content/82/23/8218.full.pdf |
| Journal | Proceedings of the National Academy of Sciences of the United States of America |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |